Halozyme Therapeutics, Inc.
HALO
$74.93
$1.532.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 548.18M | 747.92M | 596.07M | 666.31M | 529.03M |
| Total Receivables | 316.34M | 304.62M | 308.46M | 285.74M | 214.52M |
| Inventory | 181.51M | 164.87M | 141.86M | 131.41M | 159.31M |
| Prepaid Expenses | 76.65M | 44.62M | 38.95M | 43.52M | 84.93M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.12B | 1.26B | 1.09B | 1.13B | 987.80M |
|
|
|||||
| Total Current Assets | 1.12B | 1.26B | 1.09B | 1.13B | 987.80M |
| Net Property, Plant & Equipment | 71.52M | 72.82M | 75.04M | 74.49M | 75.00M |
| Long-term Investments | 416.82M | 416.82M | 416.82M | 416.82M | 416.82M |
| Goodwill | 416.82M | 416.82M | 416.82M | 416.82M | 416.82M |
| Total Other Intangibles | 366.31M | 384.07M | 401.83M | 419.59M | 437.35M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 76.58M | 60.80M | 84.45M | 80.15M | 52.48M |
| Total Assets | 2.05B | 2.20B | 2.06B | 2.12B | 1.97B |
|
|
|||||
| Total Accounts Payable | 18.69M | 20.07M | 10.25M | 12.40M | 15.43M |
| Total Accrued Expenses | 115.59M | 130.31M | 121.80M | 96.42M | 45.86M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 7.05M | -- | 157.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 71.92M |
| Total Other Current Liabilities | -- | -- | -- | -- | 71.92M |
| Total Current Liabilities | 134.28M | 150.38M | 139.10M | 108.82M | 133.36M |
|
|
|||||
| Total Current Liabilities | 134.28M | 150.38M | 139.10M | 108.82M | 133.36M |
| Long-Term Debt | 1.51B | 1.51B | 1.51B | 1.50B | 1.50B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 28.97M | 29.39M | 23.65M | 30.76M | 30.51M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 48.80M | 27.05M | 31.11M | 21.60M | 13.65M |
| Total Liabilities | 1.72B | 1.71B | 1.70B | 1.67B | 1.68B |
|
|
|||||
| Common Stock & APIC | 118.00K | 7.72M | 123.00K | 62.01M | 30.87M |
| Retained Earnings | 361.03M | 477.96M | 359.87M | 397.63M | 260.62M |
| Treasury Stock & Other | -28.40M | -3.41M | 3.83M | -6.94M | -2.07M |
| Total Common Equity | 332.75M | 482.27M | 363.82M | 452.70M | 289.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 332.75M | 482.27M | 363.82M | 452.70M | 289.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 332.75M | 482.27M | 363.82M | 452.70M | 289.42M |
|
|
|||||